Tekamlo Approval History 
- FDA approved: Yes (First approved August 26th, 2010)
- Brand name: Tekamlo
- Generic name: aliskiren and amlodipine
- Company: Novartis Corporation
- Treatment for: High Blood Pressure
Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel blocker combination indicated for the treatment of high blood pressure.
FDA Approval History for Tekamlo
| Date | Article |
|---|---|
| Aug 27, 2010 |  Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure |
See also...
Tekamlo (aliskiren and amlodipine) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
